ETS1
Protein C-ets-1
Also known as: ETS-1, ETS1_HUMAN, EWSR2, FLJ10768
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P14921
- Gene
- ETS1
- Ensembl
- ENSG00000134954
- Chromosome
- 11
- Canonical length
- 441 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transcription factors
- Subcellular location
- Nucleoplasm
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of the ETS family of transcription factors, which are defined by the presence of a conserved ETS DNA-binding domain that recognizes the core consensus DNA sequence GGAA/T in target genes. These proteins function either as transcriptional activators or repressors of numerous genes, and are involved in stem cell development, cell senescence and death, and tumorigenesis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene.[provided by RefSeq, Jul 2011]
Canonical amino-acid sequenceUniProt
441 residues, UniProt reviewed canonical sequence.
>P14921|ETS1
1 MKAAVDLKPT LTIIKTEKVD LELFPSPDME CADVPLLTPS SKEMMSQALK ATFSGFTKEQ
61 QRLGIPKDPR QWTETHVRDW VMWAVNEFSL KGVDFQKFCM NGAALCALGK DCFLELAPDF
121 VGDILWEHLE ILQKEDVKPY QVNGVNPAYP ESRYTSDYFI SYGIEHAQCV PPSEFSEPSF
181 ITESYQTLHP ISSEELLSLK YENDYPSVIL RDPLQTDTLQ NDYFAIKQEV VTPDNMCMGR
241 TSRGKLGGQD SFESIESYDS CDRLTQSWSS QSSFNSLQRV PSYDSFDSED YPAALPNHKP
301 KGTFKDYVRD RADLNKDKPV IPAAALAGYT GSGPIQLWQF LLELLTDKSC QSFISWTGDG
361 WEFKLSDPDE VARRWGKRKN KPKMNYEKLS RGLRYYYDKN IIHKTAGKRY VYRFVCDLQS
421 LLGYTPEELH AMLDVKPDAD ELocalizationUniProt · AlphaFold · HPA
Whether an antibody against ETS1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.5
- Highest tissue expression
- 253 nTPM
Expression across tissuesHPA
Tissue
- thymus: 253 nTPM
- lymph node: 215 nTPM
- tonsil: 196 nTPM
- spleen: 143 nTPM
- appendix: 110 nTPM
- adipose tissue: 82 nTPM
Single-cell type
- t-cells: 739 nCPM
- nk-cells: 689 nCPM
- vascular endothelial cells: 391 nCPM
- innate lymphoid cells: 388 nCPM
- melanocytes: 279 nCPM
- lymphatic endothelial cells: 249 nCPM
Immune cell
- basophil: 44 nTPM
- T-reg: 32 nTPM
- naive CD4 T-cell: 31 nTPM
- MAIT T-cell: 28 nTPM
- memory CD4 T-cell: 26 nTPM
- NK-cell: 26 nTPM
Brain region
- thalamus: 21 nTPM
- midbrain: 20 nTPM
- pons: 18 nTPM
- medulla oblongata: 17 nTPM
- cerebral cortex: 16 nTPM
- spinal cord: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ETS1.
Disease | GeneticClinVar
2 pathogenic / likely-pathogenic of 48 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- 11q partial monosomy syndrome
- ETS1-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.39
- gnomAD pLI
- 0.78
- gnomAD missense Z
- 2.52
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell differentiation
- cell motility
- immune response
- negative regulation of cell cycle
- negative regulation of cell population proliferation
- PML body organization
- positive regulation of angiogenesis
- positive regulation of blood vessel endothelial cell migration
- positive regulation of DNA-templated transcription
- positive regulation of endothelial cell migration
- positive regulation of erythrocyte differentiation
- positive regulation of gene expression
- positive regulation of inflammatory response
- positive regulation of leukocyte adhesion to vascular endothelial cell
- positive regulation of miRNA transcription
- positive regulation of transcription by RNA polymerase II
- regulation of angiogenesis
- regulation of apoptotic process
- regulation of transcription by RNA polymerase II
- response to antibiotic
- transcription by RNA polymerase II
Molecular functions
- DNA binding
- DNA-binding transcription activator activity, RNA polymerase II-specific
- DNA-binding transcription factor activity
- DNA-binding transcription factor activity, RNA polymerase II-specific
- identical protein binding
- nucleic acid binding
- RNA polymerase II cis-regulatory region sequence-specific DNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription cis-regulatory region binding
- transcription corepressor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ets domain
- Pointed domain
- Sterile alpha motif/pointed domain superfamily
- Transforming protein C-ets
- Winged helix-like DNA-binding domain superfamily
- Winged helix DNA-binding domain superfamily
- Ets1, N-terminal flanking region of Ets domain
- ETS family
- Ets-domain
- Sterile alpha motif (SAM)/Pointed domain
- Ets1 N-terminal flanking region of Ets domain
- Protein C-ets-1, pointed domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of ETS1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ETS1 as an antibody target. Whether an autoantibody or antibody against ETS1 could matter depends on whether native ETS1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ETS1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ETS1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...